Explore recent issues of Contract Pharma covering key industry trends.
Read the full digital version of our magazine online.
Behind every facility expansion, technology investment, and quality milestone in the CDMO sector is a leadership team making deliberate choices about where to focus, how to grow, and when to take calculated risks.
Stay informed! Subscribe to Contract Pharma for industry news and analysis.
Get the latest updates and breaking news from the pharmaceutical and biopharmaceutical industry.
Discover the newest partnerships and collaborations within the pharma sector.
Keep track of key executive moves and promotions in the pharma and biopharma industry.
Updates on the latest clinical trials and regulatory filings.
Stay informed with the latest financial reports and updates in the pharma industry.
A video roundup of the week’s top industry news stories.
Expert Q&A sessions addressing crucial topics in the pharmaceutical and biopharmaceutical world.
In-depth articles and features covering critical industry developments.
Access exclusive industry insights, interviews, and in-depth analysis.
Insights and analysis from industry experts on current pharma issues.
A one-on-one video interview between our editorial teams and industry leaders.
Listen to expert discussions and interviews in pharma and biopharma.
Contract Pharma Stream offers a centralized destination where users can watch expert-led sessions anytime, anywhere
A detailed look at the leading US players in the global pharmaceutical and BioPharmaceutical industry.
Browse companies involved in pharmaceutical manufacturing and services.
Comprehensive company profiles featuring overviews, key statistics, services, and contact details.
A comprehensive glossary of terms used in the pharmaceutical and biopharmaceutical industry.
Watch in-depth videos featuring industry insights and developments.
Download in-depth eBooks covering various aspects of the pharma industry.
Access detailed whitepapers offering analysis on industry topics.
View and download brochures from companies in the pharmaceutical sector.
Explore content sponsored by industry leaders, providing valuable insights.
Stay updated with the latest press releases from pharma and biopharma companies.
Explore top companies showcasing innovative pharma solutions.
Meet the leaders driving innovation and collaboration.
Engage with sessions and panels on pharma’s key trends.
Hear from experts shaping the pharmaceutical industry.
Join online webinars discussing critical industry topics and trends.
A comprehensive calendar of key industry events around the globe.
Live coverage and updates from major pharma and biopharma shows.
Find advertising opportunities to reach your target audience with Contract Pharma.
Review the editorial standards and guidelines for content published on our site.
Understand how Contract Pharma handles your personal data.
View the terms and conditions for using the Contract Pharma website.
What are you searching for?
3F, No.95, Guangfu North Road , Songshan District, Taipei, 105, TW
What customers and inspectors want to see in 2026—and where contract manufacturers are still falling short.
By: Niamh Bisset
Sigfried adds API and specialty-chemistry assets; SK Capital retains finished-dose platform Halo.
By: Charlie Sternberg
Aims to become one of the world’s top three injectable CDMOs
Expands Adragos’ sterile injectables network, adding high-volume pre-filled syringe manufacturing capabilities to its vial and ampoule filling operations.
By: Kristin Brooks
How CDMOs must evolve beyond Annex 1.
Released By Grand River Aseptic Manufacturing
Released By Upperton
The decision is based on the Phase 3 Breakwater trial, which showed improvements in progression‑free and overall survival.
Water for injection (WFI) sits at the heart of injectable drug manufacturing.
Released By ROIS CDMO
As increasing trial complexity becomes a regulatory risk, sponsor expectations of CROs and data partners are changing.
Applied’s lead drug candidate is a novel central nervous system (CNS) penetrant Aldose Reductase Inhibitor (ARI) for the treatment of CNS rare metabolic diseases.
The site will be the company’s latest injectable medicine and device manufacturing facility.
By: Patrick Lavery
Extractables and Leachables (E&L) issues are quietly derailing nearly one in five drug applications.
Released By Solvias
How Ropack’s evolution from service provider to strategic CMO partner reflects broader shifts in manufacturing, packaging, and quality expectations.
Released By Ropack Pharma Solutions
Establishes new, dedicated non-bacterial beta-lactam manufacturing facility.
Will produce essential generic injectable medicines currently on the FDA's drug shortage list.
Enter the destination URL
Or link to existing content
Enter your account email.
A verification code was sent to your email, Enter the 6-digit code sent to your mail.
Didn't get the code? Check your spam folder or resend code
Set a new password for signing in and accessing your data.
Your Password has been Updated !
